Optima Health PLC (AIM:OPT, OTC:OHLTF, FRA:J3N) said full-year revenue rose around 15% to approximately £121 million for the year ended 31 March 2026, in line with market expectations, as the occupational health and wellbeing services provider continued to grow its UK and Ireland platform.
The AIM-listed group said adjusted EBITDA for FY26 is expected to be around 10% ahead of previous market expectations, as previously announced. It also recognised £4.7 million of other income relating to a previously disclosed procurement matter.
A major focus of the update was Optima’s £100 million acquisition of PAM Healthcare Limited, completed on 26 March 2026. The company described the deal as transformational, saying it materially expands the group’s scale, capabilities and market reach. Integration is already underway, with £1.3 million of annualised cost synergies delivered by 1 June.
Optima ended March with net debt, excluding leases, of £94.4 million, comprising £21.6 million of cash and £116 million of debt. Net debt reduced after the period-end following repayment of a £30 million shareholder bridging loan linked to the PAM deal, using proceeds from an underwritten open offer completed in April. Full-year results are expected in August 2026.
